BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37317583)

  • 1. Controlled ovarian hyperstimulation in breast cancer patients: Does oestrogen receptor status make a difference?
    Sii S; Polyakov A; Rozen G; Agresta F; Stern K
    Aust N Z J Obstet Gynaecol; 2023 Dec; 63(6):774-779. PubMed ID: 37317583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles.
    Balayla J; Tulandi T; Buckett W; Holzer H; Steiner N; Shrem G; Volodarsky-Perel A
    J Assist Reprod Genet; 2020 Apr; 37(4):913-921. PubMed ID: 32144524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
    Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
    Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
    Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
    Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
    Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
    Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
    J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
    Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
    Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
    J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
    Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
    Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary breast cancer and fertility preservation outcomes.
    Arab S; Tulandi T; Buckett W
    J Assist Reprod Genet; 2022 May; 39(5):1163-1168. PubMed ID: 35403930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
    Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women.
    Volodarsky-Perel A; Cai E; Tulandi T; Son WY; Suarthana E; Buckett W
    Reprod Biomed Online; 2020 Feb; 40(2):215-222. PubMed ID: 31953011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.